- Trials with a EudraCT protocol (22)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
22 result(s) found for: Fear Response.
Displaying page 1 of 2.
EudraCT Number: 2016-005013-47 | Sponsor Protocol Number: FAAH2 | Start Date*: 2017-02-28 | |||||||||||
Sponsor Name:Linköping University | |||||||||||||
Full Title: Effects of the FAAH inhibitor PF-04457845 on fear extinction in healthy volunteers | |||||||||||||
Medical condition: Healthy volunteers (extinction of fear) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023849-30 | Sponsor Protocol Number: CSCAbrein&cognitie1-04 | Start Date*: Information not available in EudraCT |
Sponsor Name:University of Amsterdam | ||
Full Title: The effects of MR and GR blockade on the reconsolidation and extinction of fear memories | ||
Medical condition: Fear conditioning acquisition, reconsolidation and extinction in healthy male subjects. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002392-10 | Sponsor Protocol Number: S59302 | Start Date*: 2017-02-02 |
Sponsor Name:UZ Leuven | ||
Full Title: Reconsolidation interference versus retrieval interference as the basis for experimental amnesia in humans – The effect of drug state at memory retrieval | ||
Medical condition: Experimental study with healthy participants recruited from the general population; no vulnerable individuals or clinical groups will be involved. Our objective is to test wether the internal drug ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-003739-62 | Sponsor Protocol Number: 2021-74835 | Start Date*: 2021-06-23 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: BOOSTCAMP: Boosting the endocannabinoid system before the treatment of anxiety symptoms | ||
Medical condition: PTSD and anxiety disorders | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000133-13 | Sponsor Protocol Number: 2020-01131 | Start Date*: 2022-05-05 | |||||||||||
Sponsor Name:Universitätsmedizin Göttingen | |||||||||||||
Full Title: Glucocorticoid enhancement of food exposure therapy in Binge Eating Disorder | |||||||||||||
Medical condition: Binge-Eating-Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000712-30 | Sponsor Protocol Number: ABR-71432 | Start Date*: 2021-06-07 | |||||||||||
Sponsor Name:Radboudumc | |||||||||||||
Full Title: Targeted glucocorticoid administration to improve safety learning in PTSD patients with HPA axis dysregulation | |||||||||||||
Medical condition: Posttraumatic Stress Disorder (PTSD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002407-18 | Sponsor Protocol Number: | Start Date*: 2012-08-14 |
Sponsor Name:University of Dundee and NHS Tayside [...] | ||
Full Title: DPP4 inhibitors in Type 1 Diabetes | ||
Medical condition: Type 1 Diabetes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-003191-39 | Sponsor Protocol Number: | Start Date*: 2013-01-21 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: The effect of a single-dose of d-cycloserine on the basic effects of cognitive-behaviour therapy for panic disorder - a randomized placebo-controlled trial | |||||||||||||
Medical condition: DSM-IV Panic disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003542-68 | Sponsor Protocol Number: | Start Date*: 2016-01-27 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: The effect of single-dose losartan on the basic effects of cognitive-behaviour therapy for panic disorder - a randomized double blind placebo-controlled trial | |||||||||||||
Medical condition: DSM panic disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003659-19 | Sponsor Protocol Number: R317573DEP2002 | Start Date*: 2006-09-14 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Double Blind, Placebo- and Active-Controlled, Randomized, Sequential Group, Multiple Dose Study to Examine the Effect of the CRF1-Receptor Antagonist R317573 on 7.5% CO2-Inhalation Induced Anxiet... | |||||||||||||
Medical condition: Anxiety disorders and depression | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002968-27 | Sponsor Protocol Number: INTERMEDIATE-01 | Start Date*: 2020-02-18 | |||||||||||
Sponsor Name:Centre François Baclesse | |||||||||||||
Full Title: Multicentric phase III trial comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration (3.7 GBq I131 after rhTSH) versus decision o... | |||||||||||||
Medical condition: Differentiated thyroid cancer - subgroup of patients with intermediate risk of postoperative residual disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023044-32 | Sponsor Protocol Number: DCS-fMRIPanik | Start Date*: 2011-08-10 |
Sponsor Name:Charité Universitaetsmedizin Berlin | ||
Full Title: Mechanisms of action in exposure therapy: Decoding the neural basis of fear extinction and its pharmacological modulation in patients with panic disorder | ||
Medical condition: panic disorder and agoraphobia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000454-22 | Sponsor Protocol Number: NL43068.058.13 | Start Date*: 2013-08-21 | |||||||||||
Sponsor Name: | |||||||||||||
Full Title: (Grand)parenting, oxytocin, and the oxytocin receptor gene: an fMRI and observational study | |||||||||||||
Medical condition: There are no medical conditions or diseases under investigation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001627-32 | Sponsor Protocol Number: CVAY736Q12301 | Start Date*: 2022-12-05 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A phase 3 randomized, double-blind study of ianalumab (VAY736) versus placebo in addition to eltrombopag in patients with primary immune thrombocytopenia (ITP) who had an insufficient response or r... | |||||||||||||
Medical condition: immune thrombocytopenia (ITP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) HU (Ongoing) IT (Ongoing) NL (Ongoing) ES (Ongoing) AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004818-34 | Sponsor Protocol Number: CTRIAL-IE-19-32 | Start Date*: 2021-04-23 | |||||||||||
Sponsor Name:Cancer Trials Ireland | |||||||||||||
Full Title: DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801). A randomised phase 3 double-blind, placebo-controlled trial of adding darolutamid... | |||||||||||||
Medical condition: Clinically localised prostate cancer defined as very high risk, or with very high risk features. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001248-67 | Sponsor Protocol Number: LIN4113 | Start Date*: 2014-01-14 | |||||||||||
Sponsor Name:almirall | |||||||||||||
Full Title: CLINICAL TRIAL PHASE IIIb to evaluate predictors of response to linaclotide in patients with irritable bowel syndrome and explore the impact on intestinal symptoms | |||||||||||||
Medical condition: Irritable bowel syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002790-94 | Sponsor Protocol Number: 200828 | Start Date*: 2020-09-16 | |||||||||||
Sponsor Name:SLSO | |||||||||||||
Full Title: The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density – A Single Dose Randomized, Double Blind, Placebo-Controlled Phase 2 Positron Emission Tomography Study | |||||||||||||
Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002063-60 | Sponsor Protocol Number: PRN1008-018(EFC17093) | Start Date*: 2020-11-12 | |||||||||||
Sponsor Name:Principia Biopharma, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study with an Open-Label Extension to Evaluate the Efficacy and Safety of Oral Rilzabrutinib (PRN1008) in Adults... | |||||||||||||
Medical condition: Immune Thrombocytopenia (ITP) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) GB (GB - no longer in EU/EEA) PL (Trial now transitioned) AT (Completed) NO (Trial now transitioned) FR (Trial now transitioned) HU (Ongoing) IT (Ongoing) NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000615-23 | Sponsor Protocol Number: UC-IMM-2101 | Start Date*: 2021-06-17 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:UNICANCER | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Randomized phase III trial of standard immunotherapy (IO) by checkpoint inhibitors, versus reduced dose intensity of IO in patients with metastatic cancer in response after 6 months of standard IO | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Oncologic metastatic tumour (lung cancer (K), renal cell K (except IMDC favorable-risk treated TKI / immunotherapy [IO] combination), head and neck K, bladder K, triple negative breast K, Merkel K ... | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001302-30 | Sponsor Protocol Number: ACOVACT | Start Date*: 2020-04-15 | ||||||||||||||||||||||||||
Sponsor Name:Medical University of Vienna | ||||||||||||||||||||||||||||
Full Title: A multicenter, randomized, active controlled, open label, platform trial on the efficacy and safety of experimental therapeutics for patients with COVID-19 (caused by infection with severe acute re... | ||||||||||||||||||||||||||||
Medical condition: Infection with SARS-COV-2 (=COVID-19) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: AT (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.